Certain drugs used to treat HIV may have a role in preventing SARS-CoV-2 infections, according to preliminary data that may help explain why people living with the condition have not appeared to be at higher risk for serious COVID-19 despite being generally more vulnerable to infections.
FDA has cleared the IND for S-217622, a once-daily investigational oral antiviral therapy, enabling the global phase 3 trial to proceed as part of the ACTIV-2 program for COVID-19 This NIH-supported
Knowing the steps to stop this virus and actually taking those steps in society are two very different things. However, the weapons available to fight this variant are greater now
hospital system is already being taxed and will be taxed. now, a lot of people don t understand what is available to them, and many people that are infected are rushing to trying to get the latest protease inhibitor, et cetera, et cetera. if you do have omicron, if you have mild symptoms, just stay home, isolate, hydrate, take things for pain and not spread it to other people, show in a way it feels a little bit better, and in another way it feels a lot more homogenous. so let s talk about one of the reasons that it might seem more ominous hand that s because nearly as many children are hospitalized with covid right now as the peak in september. that s where we re seeing a little bit of difference in the type of hospitalizations. is there a reason why? is it just because of the sheer number of cases? or is it that omicron could be impacting kids differently than some of these other variants? well, remember, ryan, that children are still not vaccinated to the same rate as adults, an